Stock Information
Vertex Pharmaceuticals Inc (VRTX)
Ticker Symbol: VRTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $111,308.99 mil
Piotroski score: 5
PE Ratio: 28.4987
EPS (TTM): 15.3331
Revenue (TTM): $46.84 M
Dividend Yield: N/A%
ROE: 22.7%
Latest News
-
Is Vertex Pharmaceuticals' Empire in Trouble?
Thu, Apr 16, 2026 7:46 PM
-
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
Thu, Apr 16, 2026 6:58 PM
-
Vertex Pharmaceuticals Incorporated : 2025 Corporate Responsibility Report
Thu, Apr 16, 2026 12:00 PM
-
Vertex Pharmaceuticals Incorporated : 2025 Data Summary
Thu, Apr 16, 2026 12:00 PM
-
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Tue, Apr 14, 2026 2:00 PM
-
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Tue, Apr 14, 2026 12:15 PM
-
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
Sat, Apr 11, 2026 12:58 PM
-
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
Fri, Apr 10, 2026 9:50 PM
-
Did Halozyme’s Vertex Hypercon Licensing Deal Just Shift Halozyme Therapeutics’ (HALO) Investment Narrative?
Fri, Apr 10, 2026 6:12 PM
-
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Fri, Apr 10, 2026 1:00 PM
Key Financials
Financial data not available
